Class information for:
Level 1: CANCER TESTIS ANTIGEN//NY ESO 1//MAGE

Basic class information
Class id #P Avg. number of
references		 Database coverage
of references
1375 2692 44.6 91%


Bar chart of Publication_year

Last years might be incomplete

Hierarchy of classes
The table includes all classes above and classes immediately below the current class.


Cluster id Level Cluster label #P
0 4 BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY 4064930
10 3       IMMUNOLOGY//JOURNAL OF IMMUNOLOGY//IMMUNOL 134299
140 2             IMMUNOTHERAPY//DENDRITIC CELLS//CANCER IMMUNOLOGY IMMUNOTHERAPY 23462
1375 1                   CANCER TESTIS ANTIGEN//NY ESO 1//MAGE 2692

Terms with highest relevance score


rank Term termType Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 CANCER TESTIS ANTIGEN authKW 1864831 9% 67% 247
2 NY ESO 1 authKW 771847 4% 69% 99
3 MAGE authKW 616697 3% 63% 86
4 NEW YORK BRANCH address 574534 4% 44% 115
5 CELLULAR GENET UNIT address 351854 2% 48% 64
6 TUMOR ANTIGEN authKW 312343 5% 20% 138
7 MAGE A authKW 249976 1% 96% 23
8 CLIN ONCOIMMUNOL address 241731 2% 42% 51
9 GAGE authKW 240297 1% 76% 28
10 SEREX authKW 228608 2% 40% 51

Web of Science journal categories


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with term
in class
1 Oncology 25221 50% 0% 1346
2 Immunology 13413 34% 0% 926
3 Medicine, Research & Experimental 3709 15% 0% 396
4 Pathology 307 4% 0% 100
5 Biotechnology & Applied Microbiology 171 5% 0% 132
6 Dermatology 165 2% 0% 65
7 Cell Biology 158 6% 0% 163
8 Hematology 85 3% 0% 69
9 Genetics & Heredity 83 4% 0% 103
10 Biochemical Research Methods 53 2% 0% 67

Address terms


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 NEW YORK BRANCH 574534 4% 44% 115
2 CELLULAR GENET UNIT 351854 2% 48% 64
3 CLIN ONCOIMMUNOL 241731 2% 42% 51
4 LUDWIG CANC 227132 10% 7% 272
5 LAUSANNE BRANCH 190397 3% 20% 84
6 SURG BRANCH 183009 5% 12% 130
7 BRUSSELS BRANCH 131017 2% 22% 53
8 HUMAN IMMUNE THER Y 104969 1% 51% 18
9 LUDWIG CLIN TRIAL 91480 0% 73% 11
10 MULTIDISCIPLINARY ONCOL 80611 1% 19% 38

Journals


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class
1 JOURNAL OF IMMUNOTHERAPY 50931 3% 5% 87
2 CANCER IMMUNOLOGY IMMUNOTHERAPY 41348 5% 3% 126
3 INTERNATIONAL JOURNAL OF CANCER 22580 7% 1% 201
4 CLINICAL CANCER RESEARCH 9795 4% 1% 114
5 JOURNAL OF IMMUNOLOGY 7279 7% 0% 188
6 CANCER RESEARCH 5929 5% 0% 145
7 CANCER IMMUNOLOGY RESEARCH 4244 0% 3% 13
8 JOURNAL OF EXPERIMENTAL MEDICINE 3695 2% 1% 64
9 MELANOMA RESEARCH 3677 1% 1% 24
10 EXPERT OPINION ON BIOLOGICAL THERAPY 2134 1% 1% 20

Author Key Words


Rank Term Chi square Shr. of publ. in
class containing
term		 Class's shr. of
term's tot. occurrences		 #P with
term in
class		 LCSH search Wikipedia search
1 CANCER TESTIS ANTIGEN 1864831 9% 67% 247 Search CANCER+TESTIS+ANTIGEN Search CANCER+TESTIS+ANTIGEN
2 NY ESO 1 771847 4% 69% 99 Search NY+ESO+1 Search NY+ESO+1
3 MAGE 616697 3% 63% 86 Search MAGE Search MAGE
4 TUMOR ANTIGEN 312343 5% 20% 138 Search TUMOR+ANTIGEN Search TUMOR+ANTIGEN
5 MAGE A 249976 1% 96% 23 Search MAGE+A Search MAGE+A
6 GAGE 240297 1% 76% 28 Search GAGE Search GAGE
7 SEREX 228608 2% 40% 51 Search SEREX Search SEREX
8 MAGE 3 151544 1% 64% 21 Search MAGE+3 Search MAGE+3
9 MAGE 1 148974 1% 77% 17 Search MAGE+1 Search MAGE+1
10 MAGE A3 146309 1% 56% 23 Search MAGE+A3 Search MAGE+A3

Core articles
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c:
(1) Number of references referring to publications in the class.
(2) Share of total number of active references referring to publications in the class.
(3) Age of the article. New articles get higher score than old articles.
(4) Citation rate, normalized to year.


Rank Reference # ref. in
cl.		 Shr. of ref. in
cl.		 Citations
1 ESFANDIARY, A , GHAFOURI-FARD, S , (2015) NEW YORK ESOPHAGEAL SQUAMOUS CELL CARCINOMA-1 AND CANCER IMMUNOTHERAPY.IMMUNOTHERAPY. VOL. 7. ISSUE 4. P. 411 -439 140 82% 2
2 FRATTA, E , CORAL, S , COVRE, A , PARISI, G , COLIZZI, F , DANIELLI, R , NICOLAY, HJM , SIGALOTTI, L , MAIO, M , (2011) THE BIOLOGY OF CANCER TESTIS ANTIGENS: PUTATIVE FUNCTION, REGULATION AND THERAPEUTIC POTENTIAL.MOLECULAR ONCOLOGY. VOL. 5. ISSUE 2. P. 164 -182 130 72% 74
3 ESFANDIARY, A , GHAFOURI-FARD, S , (2015) MAGE-A3: AN IMMUNOGENIC TARGET USED IN CLINICAL PRACTICE.IMMUNOTHERAPY. VOL. 7. ISSUE 6. P. 683 -704 105 82% 3
4 COULIE, PG , VAN DEN EYNDE, BJ , VAN DER BRUGGEN, P , BOON, T , (2014) TUMOUR ANTIGENS RECOGNIZED BY T LYMPHOCYTES: AT THE CORE OF CANCER IMMUNOTHERAPY.NATURE REVIEWS CANCER. VOL. 14. ISSUE 2. P. 135 -146 92 54% 124
5 BOON, T , COULIE, PG , VAN DEN EYNDE, BJ , VAN DER BRUGGEN, P , (2006) HUMAN T CELL RESPONSES AGAINST MELANOMA.ANNUAL REVIEW OF IMMUNOLOGY. VOL. 24. ISSUE . P. 175 -208 109 58% 378
6 NOVELLINO, L , CASTELLI, C , PARMIANI, G , (2005) A LISTING OF HUMAN TUMOR ANTIGENS RECOGNIZED BY T CELLS: MARCH 2004 UPDATE.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 54. ISSUE 3. P. 187-207 123 58% 276
7 CABALLERO, OL , CHEN, YT , (2009) CANCER/TESTIS (CT) ANTIGENS: POTENTIAL TARGETS FOR IMMUNOTHERAPY.CANCER SCIENCE. VOL. 100. ISSUE 11. P. 2014 -2021 66 81% 260
8 SALMANINEJAD, A , ZAMANI, MR , POURVAHEDI, M , GOLCHEHRE, Z , BERESHNEH, AH , REZAEI, N , (2016) CANCER/TESTIS ANTIGENS: EXPRESSION, REGULATION, TUMOR INVASION, AND USE IN IMMUNOTHERAPY OF CANCERS.IMMUNOLOGICAL INVESTIGATIONS. VOL. 45. ISSUE 7. P. 619 -640 91 70% 0
9 RENKVIST, N , CASTELLI, C , ROBBINS, PF , PARMIANI, G , (2001) A LISTING OF HUMAN TUMOR ANTIGENS RECOGNIZED BY T CELLS.CANCER IMMUNOLOGY IMMUNOTHERAPY. VOL. 50. ISSUE 1. P. 3-15 96 68% 314
10 ZENDMAN, AJW , RUITER, DJ , VAN MUIJEN, GNP , (2003) CANCER/TESTIS-ASSOCIATED GENES: IDENTIFICATION, EXPRESSION PROFILE, AND PUTATIVE FUNCTION.JOURNAL OF CELLULAR PHYSIOLOGY. VOL. 194. ISSUE 3. P. 272-288 106 63% 167

Classes with closest relation at Level 1


Rank Class id link
1 33774 CANC MICROARRAY GENES PROT//SPERM PROTEIN 17//SPAG9
2 26564 RAS DERIVED PEPTIDES//P53 PEPTIDES//RAS PEPTIDES
3 24888 CANC VACCINE DEV//INNOVAT CANC THER Y//PERSONALIZED PEPTIDE VACCINE
4 25112 GV1001//PA MSHA VACCINE//HTERTC27
5 33425 ARTIFICIAL ANTIGEN PRESENTING CELLS//ANTIGEN SPECIFIC CD8T CELLS//HLA A2 IG
6 16780 CANC VACCINE DEV PROGRAM//CANC IMMUNOL IMMUNOTHER Y//TUMOR VACCINE GRP
7 27801 NECDIN//SASH1//REGULAT MACROMOL FUNCT
8 24733 TUMOR IMMUN TOLERANCE SECT//SV40 T ANTIGEN TRANSGENIC MICE//CCDC134
9 28653 IN SITU TETRAMER STAINING//CONDITIONAL LIGANDS//EX VIVO PHENOTYPING
10 13629 TUMOR IMMUNOL BIOL//SIPULEUCEL T//5T4

Go to start page